Ftse Mib
33.986,90
1,06%
DAX
18.175,21
1,01%
S&P 500
5.180,74
1,03%
NASDAQ
16.349,25
1,19%
Bitcoin
63.764,52
0,95%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Evaxion Biotech AS (EVAX) Evaxion Biotech AS (EVAX) Notizie

Evaxion Biotech AS

EVAX
3,91
-0,04 (-1,01%)
07 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202423:01EDGAR2Form F-1 - Registration statement for certain foreign..
17/4/202414:00GLOBEEvaxion Announces Phase 2 Clinical Trial Update: First..
02/4/202413:00GLOBEEvaxion and Undisclosed Collaborator Announce Encouraging..
27/3/202412:30GLOBEEvaxion Announces Business Update and Full Year 2023..
19/3/202412:30GLOBEEvaxion Hosts R&D Day and Unveils the Broad Potential of Its..
29/2/202413:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/2/202413:30GLOBEEvaxion to Host R&D Day on March 19, 2024, Highlighting its..
20/2/202413:32EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202413:30GLOBEEvaxion Announces Successful Completion of the Initial..
07/2/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
07/2/202414:30GLOBEEvaxion Regains Compliance with Nasdaq Minimum Bid Price..
06/2/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/2/202414:30GLOBEEvaxion Announces Closing of $15 Million Public Offering
05/2/202415:09EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/2/202413:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
02/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
01/2/202415:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/2/202415:20GLOBEEvaxion Biotech Announces Pricing of $15 Million Public..
31/1/202423:10EDGAR2Form F-1/A - Registration statement for certain foreign..
31/1/202415:26EDGAR2Form F-1/A - Registration statement for certain foreign..
30/1/202421:16EDGAR2Form F-1/A - Registration statement for certain foreign..
26/1/202422:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202420:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202414:30GLOBEEvaxion to Develop Tailored Novel Cancer Vaccines Based upon..
22/1/202422:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/1/202422:30GLOBEEvaxion Announces Completion of ADS Ratio Change
12/1/202423:17EDGAR2Form F-1 - Registration statement for certain foreign..
12/1/202415:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/1/202414:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202414:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202414:30GLOBEEvaxion Announces Plan to Implement ADS Ratio Change
21/12/202322:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202322:30GLOBEEvaxion Biotech Announces Closing of Private Placement
19/12/202322:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
19/12/202322:15GLOBEEvaxion Announces Business Update and Third Quarter 2023..
19/12/202315:25GLOBEEvaxion Biotech Announces Private Placement Financing
19/12/202314:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202322:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202314:27GLOBEEvaxion to Unveil Potentially Groundbreaking AI-Immunology™..
17/11/202315:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202314:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
15/11/202314:00GLOBEEvaxion Presents Proof-of-Principle for Its Unique AI Model..
06/11/202316:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
06/11/202316:12GLOBEEvaxion Shares Latest EVX-01 Phase 2 Clinical Data in..
31/10/202316:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202316:14GLOBEEvaxion Announces Encouraging Initial Phase 2 Clinical Data..
26/10/202314:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/10/202314:30GLOBENew and Exciting Clinical Data on Evaxion’s..
Apertura: 3,99 Min: 3,79 Max: 4,16
Chiusura: 3,95

La tua Cronologia

NASDAQ
EVAX
Evaxion Biotech AS
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network